Observational findings reveal APC leads to weight loss in over 60% of RYGB patients, suggesting early treatment may enhance long-term outcomes.
APC is a safe and simple option for post-RYGB weight regain, achieving clinically meaningful weight loss in over 60% of patients. Early response is a predictor of long-term benefit and may guide timely initiation of adjunctive therapies in non-responders.
No takes yet. Share an insight, caveat, or question.
Rodríguez-Carrillo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: